H2020-PHC-2014-2015
H2020-PHC-2014-2015
- Programme
- H2020
- Funded projects (dataset)
- 192
- EU contribution (sum)
- €1,063,052,755
- Portal deadline
- —
Leading topic in historical projects: PHC-01-2014
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- UNIVERSITY COLLEGE LONDON7 coordinated
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5 coordinated
- Leiden University Medical Center4 coordinated
- ERASMUS MC4 coordinated
- INSERM4 coordinated
- REGIONH4 coordinated
- STICHTING AMSTERDAM UMC4 coordinated
- OLLSCOIL NA GAILLIMHE4 coordinated
- KI3 coordinated
- UNIVERSITE LYON 1 CLAUDE BERNARD3 coordinated
- CNR2 coordinated
- TECHNICAL UNIVERSITY OF DENMARK DTU2 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- UOXF6 topic projects
- IDIBAPS-CERCA5 topic projects
- HOSPITAL CLINIC DE BARCELONA5 topic projects
- UNEW4 topic projects
- KING'S COLLEGE LONDON4 topic projects
- LMU MUENCHEN4 topic projects
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 12 shared
- UNIVERSITY COLLEGE LONDON · INSERM8 shared
UK ↔ FR
- ERASMUS MC · INSERM7 shared
NL ↔ FR
- ERASMUS MC · UNIVERSITY COLLEGE LONDON7 shared
NL ↔ UK
- 7 shared
- KI · KING'S COLLEGE LONDON7 shared
SE ↔ UK
- 7 shared
- ERASMUS MC · LMU MUENCHEN6 shared
NL ↔ DE
- 6 shared
- KI · UNIVERSITY COLLEGE LONDON6 shared
SE ↔ UK
- 6 shared
- STICHTING AMSTERDAM UMC · STICHTING VU6 shared
NL ↔ NL
- ERASMUS MC · STICHTING AMSTERDAM UMC5 shared
NL ↔ NL
- KI · Leiden University Medical Center5 shared
SE ↔ NL
- INSERM · ISTITUTO SUPERIORE DI SANITA5 shared
FR ↔ IT
- STICHTING RADBOUD UNIVERSITEIT · INSERM5 shared
NL ↔ FR
- 5 shared
- KI · ISTITUTO SUPERIORE DI SANITA5 shared
SE ↔ IT
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 13.18
- Median orgs / project
- 12
- Min / max orgs
- 4 – 47
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- United Kingdom351
- Germany342
- Netherlands249
- Spain244
- France242
- Italy221
- Sweden96
- Belgium95
- Switzerland78
- Denmark69
- Greece65
- Austria57
- Finland46
- Ireland41
- Portugal38
- United States34
- Israel29
- Norway28
Organization types
- university372 orgs · 1053 rows
- research_institute291 orgs · 578 rows
- sme332 orgs · 379 rows
- company153 orgs · 199 rows
- public_body107 orgs · 178 rows
- other123 orgs · 144 rows
Topics in funded projects
- PHC-01-2014PHC-01-2014· 14 projects
- PHC-26-2014PHC-26-2014· 14 projects
- PHC-13-2014PHC-13-2014· 10 projects
- PHC-14-2015PHC-14-2015· 10 projects
- PHC-10-2014PHC-10-2014· 9 projects
- PHC-17-2014PHC-17-2014· 8 projects
- PHC-32-2014PHC-32-2014· 8 projects
- PHC-03-2015PHC-03-2015· 8 projects
- PHC-11-2015PHC-11-2015· 8 projects
- PHC-02-2015PHC-02-2015· 7 projects
- PHC-25-2015PHC-25-2015· 7 projects
- PHC-15-2015PHC-15-2015· 7 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| EU-ToxRisk An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century | H2020 | €27,798,299 |
| EAVI2020 European AIDS Vaccine Initiative 2020 | H2020 | €22,948,022 |
| EHVA European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | H2020 | €22,188,522 |
| COMPARE COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe | H2020 | €20,817,771 |
| TBVAC2020 TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | H2020 | €18,200,000 |
| PERFORM Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union | H2020 | €17,997,666 |
| U-PGx Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen | H2020 | €14,936,613 |
| FORECEE Female cancer prediction using cervical omics to individualise screening and prevention | H2020 | €7,994,746 |
| EMI-TB Eliciting Mucosal Immunity to Tuberculosis | H2020 | €7,993,660 |
| ChiLTERN Children’s Liver Tumour European Research Network | H2020 | €7,941,665 |
| ENSAT-HT Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension | H2020 | €7,607,337 |
| I-MOVE-plus I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | H2020 | €7,482,729 |
| SCIDNET DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) | H2020 | €6,926,313 |
| TETRA Autologous Stem Cell Seeded Tissue Engineered Trachea | H2020 | €6,828,884 |
| MOCHA Models of Child Health Appraised | H2020 | €6,821,232 |